Lintao Cai
Ph.D, Professor, Founding Director
Institute of Biomedicine and Biotechnology
Shenzhen Institute of Advanced Technology,
Chinese Academy of Sciences
1068 Xueyuan Avenue, Shenzhen University Town,
Nanshan, Shenzhen 518055, China
Tel: +86-755-86392210 Fax: +86-755-86392299
E-mail: lt.cai@siat.ac.cn
Web site: https://caigroup.siat.ac.cn/
Biography
Lintao Cai, Professor, AIMBE Fellow, IAAM Fellow, Founding Director of Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences (CAS). He received his Ph.D. degree in Physical Chemistry from Xiamen University in 1995. From 1999 to 2001, he was sponsored by Japan Society of the Promotion of Science (JSPS) and worked as Research Fellow in Institute of Scientific and Industrial Research at Osaka University. He joined the Center for Nanoscale Science and Technology at Rice University in 2001 and Department of Electrical Engineering at the Pennsylvania State University between 2002 and 2007. Dr. Cai’s scientific research areas include nanomedicine and biomaterials to explore in vivo molecular imaging nanoprobes, smart drug delivery system and tumor-targeted phototherapy.
He has more than 265 publications in peer reviewed Journals (i.e., Nat Nanotech, Nat Chem Biology, Sci Adv, Matter, JACS, Angew Chem Int Ed, Nano Lett, ACS Nano, Adv Mater, etc, H index 80) with 21100 citations, 160 authorized patents and 9 PCT international patents. He is one of the top 2% of world’s top scientists, an expert receiving special government allowance from the State Council. He is an invited editorial board member and executive director of the Chinese Chemical Letters journal, and an editorial board member of the Progress in Biochemistry and Biophysics journal. He is a council member of Chinese Chemical Society (CCS), a Board of Director for Chinese American Society of Nanomedicine and Nanobiotechnology (CASNN)，a member of American Chemical Society (ACS) and Royal Society of Chemistry (RSC).
He has more than 265 publications in peer reviewed Journals (i.e., Nat Nanotech, Nat Chem Biology, Sci Adv, Matter, JACS, Angew Chem Int Ed, Nano Lett, ACS Nano, Adv Mater, etc, H index 80) with 21100 citations, 160 authorized patents and 9 PCT international patents. He is one of the top 2% of world’s top scientists, an expert receiving special government allowance from the State Council. He is an invited editorial board member and executive director of the Chinese Chemical Letters journal, and an editorial board member of the Progress in Biochemistry and Biophysics journal. He is a council member of Chinese Chemical Society (CCS), a Board of Director for Chinese American Society of Nanomedicine and Nanobiotechnology (CASNN)，a member of American Chemical Society (ACS) and Royal Society of Chemistry (RSC).